Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
about
Therapeutic applications of histone deacetylase inhibitors in sarcoma.Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cellsRetrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide.Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma
P2860
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@ast
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@en
type
label
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@ast
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@en
prefLabel
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@ast
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@en
P2093
P2860
P1433
P1476
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy.
@en
P2093
Albrecht Stenzinger
Andreas E Kulozik
Anne Dittmar
Claudia Blattmann
Markus Thiemann
Peter E Huber
Susanne Oertel
Volker Ehemann
P2860
P2888
P356
10.1186/S13014-015-0455-Z
P577
2015-07-16T00:00:00Z
P5875
P6179
1004087566